CELECOXIB

The solicitation seeks to award a national prime‑vendor contract, in accordance with FAR 52.216‑21, to supply the pharmaceuticals listed in the Schedule of Supplies for Defense Logistics Agency (DLA), Veterans Affairs (VA), Bureau of Prisons, and Indian Health Service customers through the Prime Vendor Programs. The contract’s primary goal is to ensure consistent product availability and to secure volume‑based, committed‑use pricing for the estimated annual demand. Offerors must provide their best technical and price terms, and the Government reserves the right to discuss, reject, or award items individually, including quantities less than those offered, unless the offeror specifies otherwise. All proposals must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) as two separate volumes: a Non‑Price Proposal (including a signed SF 1449, complete representations and certifications, and a certification of the country of origin for all active pharmaceutical ingredients and TAA compliance) and a Price Proposal covering six CLINs with exact quantities for 100 mg, 200 mg, 400 mg, and 50 mg capsules in specified bottle counts. Prices must be firm for 30 calendar days, product samples are required when indicated, and offers must be accompanied by the required documentation and registration in DIBBS. The solicitation also allows multiple awards and partial quantity acceptances, and the Government may waive minor irregularities in the interest of public benefit.

Notice ID

ba1032b4a7a840d6bea38dce6b0bdce0

Solicitation Number

SPE2D2-20-R-0075

NAICS Code

325412

Classification Code

6505